Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Acquired drug resistance during inadequate therapy in a young child with tuberculosis.

Garcia-Prats AJ, Willemse M, Seifart HI, Jordaan AM, Werely CJ, Donald PR, Schaaf HS.

Pediatr Infect Dis J. 2014 Aug;33(8):883-5. doi: 10.1097/INF.0000000000000336.

PMID:
25222312
2.

Discordant drug susceptibility for mycobacterium tuberculosis within families.

Seddon JA, Jordaan AM, Victor TC, Schaaf HS.

Pediatr Infect Dis J. 2012 Jul;31(7):783-5. doi: 10.1097/INF.0b013e3182567c20.

PMID:
22466320
3.

Impact of drug resistance on clinical outcome in children with tuberculous meningitis.

Seddon JA, Visser DH, Bartens M, Jordaan AM, Victor TC, van Furth AM, Schoeman JF, Schaaf HS.

Pediatr Infect Dis J. 2012 Jul;31(7):711-6. doi: 10.1097/INF.0b013e318253acf8.

PMID:
22411053
4.

Rifampicin-monoresistant Mycobacterium tuberculosis disease among children in Cape Town, South Africa.

Dramowski A, Morsheimer MM, Jordaan AM, Victor TC, Donald PR, Schaaf HS.

Int J Tuberc Lung Dis. 2012 Jan;16(1):76-81. doi: 10.5588/ijtld.11.0360.

5.

Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.

Schaaf HS, Victor TC, Venter A, Brittle W, Jordaan AM, Hesseling AC, Marais BJ, van Helden PD, Donald PR.

Int J Tuberc Lung Dis. 2009 Nov;13(11):1355-9.

PMID:
19861006
6.

Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco.

Chaoui I, Sabouni R, Kourout M, Jordaan AM, Lahlou O, Elouad R, Akrim M, Victor TC, El Mzibri M.

J Infect Dev Ctries. 2009 May 1;3(4):278-84.

7.

Discordance between mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing and IS6110 restriction fragment length polymorphism genotyping for analysis of Mycobacterium tuberculosis Beijing strains in a setting of high incidence of tuberculosis.

Hanekom M, van der Spuy GD, Gey van Pittius NC, McEvoy CR, Hoek KG, Ndabambi SL, Jordaan AM, Victor TC, van Helden PD, Warren RM.

J Clin Microbiol. 2008 Oct;46(10):3338-45. doi: 10.1128/JCM.00770-08. Epub 2008 Aug 20.

8.

An overview of the phenotypic and genotypic characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from four Asian countries.

Ang CF, Ong CS, Rukmana A, Pham Thi KL, Yap SF, Ngeow YF, Ho ML, Sudiro TM, Bela B, Jordaan AM, Streicher EM, Victor TC.

J Med Microbiol. 2008 Aug;57(Pt 8):1039-40. doi: 10.1099/jmm.0.47850-0. No abstract available.

PMID:
18628510
9.

Drug susceptibility testing using molecular techniques can enhance tuberculosis diagnosis.

Johnson R, Jordaan AM, Warren R, Bosman M, Young D, Nagy JN, Wain JR, Van Helden PD, Victor TC.

J Infect Dev Ctries. 2008 Feb 1;2(1):40-5.

10.

Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the western Cape of South Africa.

Victor TC, Streicher EM, Kewley C, Jordaan AM, van der Spuy GD, Bosman M, Louw H, Murray M, Young D, van Helden PD, Warren RM.

Int J Tuberc Lung Dis. 2007 Feb;11(2):195-201.

PMID:
17263291
11.

An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the western Cape, South Africa.

Johnson R, Warren R, Strauss OJ, Jordaan AM, Falmer AA, Beyers N, Schaaf HS, Murray M, Cloete K, van Helden PD, Victor TC.

Int J Tuberc Lung Dis. 2006 Dec;10(12):1412-4.

PMID:
17167961
12.

Ethambutol resistance testing by mutation detection.

Johnson R, Jordaan AM, Pretorius L, Engelke E, van der Spuy G, Kewley C, Bosman M, van Helden PD, Warren R, Victor TC.

Int J Tuberc Lung Dis. 2006 Jan;10(1):68-73.

PMID:
16466040
13.

Identification of MDR-TB Beijing/W and other Mycobacterium tuberculosis genotypes in Nairobi, Kenya.

Githui WA, Jordaan AM, Juma ES, Kinyanjui P, Karimi FG, Kimwomi J, Meme H, Mumbi P, Streicher EM, Warren R, van Helden PD, Victor TC.

Int J Tuberc Lung Dis. 2004 Mar;8(3):352-60.

PMID:
15139475
14.

Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates.

Mokrousov I, Bhanu NV, Suffys PN, Kadival GV, Yap SF, Cho SN, Jordaan AM, Narvskaya O, Singh UB, Gomes HM, Lee H, Kulkarni SP, Lim KC, Khan BK, van Soolingen D, Victor TC, Schouls LM.

J Microbiol Methods. 2004 Jun;57(3):323-35.

PMID:
15134881
15.

Molecular characteristics and global spread of Mycobacterium tuberculosis with a western cape F11 genotype.

Victor TC, de Haas PE, Jordaan AM, van der Spuy GD, Richardson M, van Soolingen D, van Helden PD, Warren R.

J Clin Microbiol. 2004 Feb;42(2):769-72.

16.

IS6110-mediated deletion polymorphism in the direct repeat region of clinical isolates of Mycobacterium tuberculosis.

Sampson SL, Warren RM, Richardson M, Victor TC, Jordaan AM, van der Spuy GD, van Helden PD.

J Bacteriol. 2003 May;185(9):2856-66.

17.

Molecular detection of early appearance of drug resistance during Mycobacterium tuberculosis infection.

Victor TC, Lee H, Cho SN, Jordaan AM, van der Spuy G, van Helden PD, Warren R.

Clin Chem Lab Med. 2002 Sep;40(9):876-81.

PMID:
12435103
18.

Isoniazid-induced transient high-level resistance in Mycobacterium tuberculosis.

Viveiros M, Portugal I, Bettencourt R, Victor TC, Jordaan AM, Leandro C, Ordway D, Amaral L.

Antimicrob Agents Chemother. 2002 Sep;46(9):2804-10.

19.

Molecular analysis of clinical isolates of Mycobacterium tuberculosis collected from patients with persistent disease in the Khartoum region of Sudan.

Sharaf-Eldin GS, Saeed NS, Hamid ME, Jordaan AM, Van der Spuy GD, Warren RM, Van Helden PD, Victor TC.

J Infect. 2002 May;44(4):244-51.

PMID:
12099732
20.

Sequence polymorphism in the rrs gene of Mycobacterium tuberculosis is deeply rooted within an evolutionary clade and is not associated with streptomycin resistance.

Victor TC, van Rie A, Jordaan AM, Richardson M, van Der Spuy GD, Beyers N, van Helden PD, Warren R.

J Clin Microbiol. 2001 Nov;39(11):4184-6.

21.

Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community.

Van Rie A, Warren R, Mshanga I, Jordaan AM, van der Spuy GD, Richardson M, Simpson J, Gie RP, Enarson DA, Beyers N, van Helden PD, Victor TC.

J Clin Microbiol. 2001 Feb;39(2):636-41.

22.

Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy.

Victor TC, Jordaan AM, van Rie A, van der Spuy GD, Richardson M, van Helden PD, Warren R.

Tuber Lung Dis. 1999;79(6):343-8.

PMID:
10694978
23.

Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis.

Victor TC, Warren R, Butt JL, Jordaan AM, Felix JV, Venter A, Sirgel FA, Schaaf HS, Donald PR, Richardson M, Cynamon MH, Van Helden PD.

J Med Microbiol. 1997 Oct;46(10):847-57.

PMID:
9364141
24.

katG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis are not infrequent.

Victor TC, Pretorius GS, Felix JV, Jordaan AM, van Helden PD, Eisenach KD.

Antimicrob Agents Chemother. 1996 Jun;40(6):1572. No abstract available.

25.

Strain-specific variation in the dnaJ gene of mycobacteria.

Victor TC, Jordaan AM, Van Schalkwyk EJ, Coetzee GJ, Van Helden PD.

J Med Microbiol. 1996 May;44(5):332-9.

PMID:
8636947
26.

Polymerase chain reaction in the diagnosis of tuberculous meningitis.

Donald PR, Victor TC, Jordaan AM, Schoeman JF, van Helden PD.

Scand J Infect Dis. 1993;25(5):613-7.

PMID:
8284646
27.

No evidence for point mutations in codons 12, 13, and 61 of the ras gene in a high-incidence area for esophageal and gastric cancers.

Victor T, Du Toit R, Jordaan AM, Bester AJ, van Helden PD.

Cancer Res. 1990 Aug 15;50(16):4911-4.

28.

A sensitive and rapid method for separating adenine nucleotides and creatine phosphate by ion-pair reversed-phase high-performance liquid chromatography.

Victor T, Jordaan AM, Bester AJ, Lochner A.

J Chromatogr. 1987 Feb 27;389(1):339-44. No abstract available.

PMID:
3571360

Supplemental Content

Loading ...
Support Center